Financhill
Sell
47

AVY Quote, Financials, Valuation and Earnings

Last price:
$182.25
Seasonality move :
3.77%
Day range:
$181.37 - $183.98
52-week range:
$156.23 - $196.41
Dividend yield:
2.03%
P/E ratio:
20.66x
P/S ratio:
1.64x
P/B ratio:
6.36x
Volume:
515K
Avg. volume:
736.9K
1-year change:
-2.81%
Market cap:
$14.1B
Revenue:
$8.8B
EPS (TTM):
$8.80

Analysts' Opinion

  • Consensus Rating
    Avery Dennison Corp. has received a consensus rating of Buy. The company's average rating is a Buy based on 7 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $202.82, Avery Dennison Corp. has an estimated upside of 11.51% from its current price of $181.88.
  • Price Target Downside
    According to analysts, the lowest downside price target is $180.00 representing 100% downside risk from its current price of $181.88.

Fair Value

  • According to the consensus of 10 analysts, Avery Dennison Corp. has 11.51% upside to fair value with a price target of $202.82 per share.

AVY vs. S&P 500

  • Over the past 5 trading days, Avery Dennison Corp. has overperformed the S&P 500 by 1.6% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Avery Dennison Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Avery Dennison Corp. has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Avery Dennison Corp. reported revenues of $2.2B.

Earnings Growth

  • Avery Dennison Corp. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Avery Dennison Corp. reported earnings per share of $2.13.
Enterprise value:
17.3B
EV / Invested capital:
--
Price / LTM sales:
1.64x
EV / EBIT:
16.31x
EV / Revenue:
1.97x
PEG ratio (5yr expected):
3.60x
EV / Free cash flow:
26.44x
Price / Operating cash flow:
22.02x
Enterprise value / EBITDA:
12.58x
Gross Profit (TTM):
$2.5B
Return On Assets:
8.16%
Net Income Margin (TTM):
7.93%
Return On Equity:
30.81%
Return On Invested Capital:
12.15%
Operating Margin:
12.8%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $8.3B $8.7B $8.8B $2.2B $2.2B
Gross Profit $2.2B $2.5B $2.5B $626.6M $635M
Operating Income $882.8M $1.1B $1.1B $279.7M $283.6M
EBITDA $1.2B $1.4B $1.4B $357.8M $367.6M
Diluted EPS $5.94 $8.33 $8.80 $2.25 $2.13
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $2.8B $3B $2.8B $3.1B $3.5B
Total Assets $8B $8B $8.1B $8.5B $8.9B
Current Liabilities $2.6B $2.9B $2.7B $3.3B $2.8B
Total Liabilities $6.2B $6B $6.1B $6.1B $6.7B
Total Equity $1.8B $2B $2.1B $2.4B $2.2B
Total Debt $2.8B $2.5B $2.6B $2B $3.2B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $859.9M $899.5M $855.8M $270.1M $312.1M
Cash From Investing -$446.9M -$284.3M -$178.2M -$50.7M -$43.4M
Cash From Financing -$327.4M -$614.3M -$351.9M -$217.7M $52.9M
Free Cash Flow $570.2M $641.3M $652.6M $217.9M $268.5M
AVY
Sector
Market Cap
$14.1B
$22.5M
Price % of 52-Week High
92.61%
72.97%
Dividend Yield
2.03%
0%
Shareholder Yield
6.07%
-2.79%
1-Year Price Total Return
-2.81%
13.1%
Beta (5-Year)
1.002
0.601
Dividend yield:
2.03%
Annualized payout:
$3.45
Payout ratio:
44.09%
Growth streak:
14 years

Technicals

8-day SMA
Sell
Level $181.92
200-day SMA
Buy
Level $173.68
Bollinger Bands (100)
Buy
Level 164.03 - 178.99
Chaikin Money Flow
Buy
Level 206.3M
20-day SMA
Buy
Level $180.44
Relative Strength Index (RSI14)
Buy
Level 58.16
ADX Line
Buy
Level 24.23
Williams %R
Neutral
Level -42.1777
50-day SMA
Buy
Level $176.36
MACD (12, 26)
Buy
Level 2.39
25-day Aroon Oscillator
Buy
Level 64
On Balance Volume
Neutral
Level 129.5M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (3.8442)
Sell
CA Score (Annual)
Level (-0.5079)
Buy
Beneish M-Score (Annual)
Level (-2.6343)
Sell
Momentum Score
Level (3)
Sell
Ohlson Score
Level (0.4552)
Buy
Piotroski F Score (Annual)
Level (9)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (10)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Avery Dennison Corp. engages in the provision of labeling and packaging materials and solutions. It operates through the Materials and Solutions Group segments. The Materials Group segment manufactures and sells pressure-sensitive label materials, films for graphic and reflective products, performance tapes and other adhesive products for industrial, medical and other applications, as well as fastener solutions. The Solutions Group segment designs, manufactures and sells a wide variety of branding and information solutions, including brand and price tickets, tags and labels, and related services, supplies and equipment. The company was founded by R. Stanton Avery in 1935 and is headquartered in Mentor, OH.

Stock Forecast FAQ

In the current month, AVY has received 7 Buy ratings 3 Hold ratings, and 0 Sell ratings. The AVY average analyst price target in the past 3 months is $202.82.

  • Where Will Avery Dennison Corp. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Avery Dennison Corp. share price will rise to $202.82 per share over the next 12 months.

  • What Do Analysts Say About Avery Dennison Corp.?

    Analysts are divided on their view about Avery Dennison Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Avery Dennison Corp. is a Sell and believe this share price will drop from its current level to $180.00.

  • What Is Avery Dennison Corp.'s Price Target?

    The price target for Avery Dennison Corp. over the next 1-year time period is forecast to be $202.82 according to 10 Wall Street analysts, 7 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.

  • Is AVY A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Avery Dennison Corp. is a Buy. 7 of 10 analysts rate the stock a Buy at this time.

  • How Can I Buy Shares Of AVY?

    You can purchase shares of Avery Dennison Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Avery Dennison Corp. shares.

  • What Is The Avery Dennison Corp. Share Price Today?

    Avery Dennison Corp. was last trading at $182.25 per share. This represents the most recent stock quote for Avery Dennison Corp.. Yesterday, Avery Dennison Corp. closed at $181.88 per share.

  • How To Buy Avery Dennison Corp. Stock Online?

    In order to purchase Avery Dennison Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
53
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 36x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Sell
30
CORT alert for Jan 2

Corcept Therapeutics, Inc. [CORT] is up 5.11% over the past day.

Buy
75
AXSM alert for Jan 2

Axsome Therapeutics, Inc. [AXSM] is down 3.83% over the past day.

Sell
50
NUTX alert for Jan 2

Nutex Health, Inc. [NUTX] is down 9.63% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock